Latest On 9 Meters Biopharma, Inc (INNT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-11-30 06:20 EST | News | Warning: INNT is at high risk of performing badly | N/A |  |
| 2020-09-26 13:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-14 08:23 EST | Insider Trade | Mark A Sirgo has acquired 21,485 shares indirectly via their spouse. | Buy | |
| 2020-09-14 08:23 EST | Insider Trade | Mark A Sirgo has directly acquired 77,000 shares and currently holds 538,784 shares. | Buy | |
| 2020-09-14 08:23 EST | Insider Trade | Mark A Sirgo has directly acquired 50,000 shares and currently holds 461,784 shares. | Buy | |
| 2020-08-24 07:21 EST | Insider Trade | John Temperato has directly acquired 70,000 shares and currently holds 615,496 shares. | Buy | |
| 2020-08-21 16:53 EST | Insider Trade | Michael T. Constantino has directly acquired 34,108 shares and currently holds 34,108 shares. | Buy | |
| 2020-08-21 04:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-18 17:25 EST | Insider Trade | Mark A Sirgo has directly acquired 100,000 shares and currently holds 411,784 shares. | Buy | |
| 2020-08-17 16:24 EST | Insider Trade | John Temperato has directly acquired 35,000 shares and currently holds 545,496 shares. | Buy | |
| 2020-08-14 09:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 01:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:08 EST | Insider Trade | John Temperato has directly acquired 189,655 shares and currently holds 239,096 shares. | Buy | |
| 2020-06-26 09:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-16 16:23 EST | Insider Trade | Mark A Sirgo has directly acquired 17,943 shares and currently holds 57,384 shares. | Buy | |
| 2020-06-15 17:10 EST | Insider Trade | John Temperato has directly acquired 10,000 shares and currently holds 49,441 shares. | Buy | |
| 2020-06-12 05:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 05:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-20 20:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 05:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-03 09:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 22:02 EST | News | Innovate Bio shareholders back merger; shares up 8% premarket | N/A | |
| 2020-04-11 21:30 EST | News | Innovate Biopharmaceuticals reports FY results | N/A | |
| 2020-04-09 12:52 EST | Stock Split | A stock split has occured on Feb 1, 2018 with a split factor of 1:10. | Neutral | |
| 2020-04-03 01:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 00:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 04:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 20:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 23:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-12 23:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 00:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-30 23:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 23:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 23:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 04:09 EST | Earnings | Earnings have been released on March 19, 2019, with -$0.12 earnings per share. | Buy | |
| 2020-01-28 04:09 EST | Earnings | Earnings have been released on November 12, 2019, with -$0.26 earnings per share. | Sell | |
| 2020-01-27 23:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-16 00:00 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-21 23:42 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-16 23:54 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-28 23:42 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-27 23:52 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-26 23:52 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-15 23:52 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-12 03:34 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-11 07:28 EST | Earnings Estimate | An EPS average of -$0.13 is estimated for the quarter ending on March 31, 2020. | N/A | |
| 2019-11-08 03:36 EST | Analyst Rating | The Analyst Target Price has decreased from $18.5 to $10. | Neutral | |
About 9 Meters Biopharma, Inc (INNT):
9 Meters Biopharma, Inc. operates as a rare, orphan, and unmet needs-focused GI company. The company is advancing its drug candidates for short bowel syndrome and celiac disease. Its product candidates include NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for short bowel syndrome; and larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease. The company's pipeline products also includes NM-004, an oral gut restricted immunomodulator and NM-003, a long-acting GLP-2 analogue, both of which are under orphan indication selection. 9 Meters Biopharma, Inc. owns global rights to its products. The company is based in Raleigh, North Carolina.
General
- Name 9 Meters Biopharma, Inc
- Symbol INNT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- Full Time Employees 8
- Last Split Factor1:10
- Last Split Date2018-02-01
- Fiscal Year EndDecember
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Web URLhttp://9meters.com
View More
Valuation
- Price/Book (Most Recent Quarter) 34.39
View More
Financials
- Most Recent Quarter 2020-06-30
- Return on Assets -193%
- Earnings Per Share -$0.49
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 23.14 million
- EBITDA -13480556
- Analyst Target Price $10
- Book Value Per Share $0.14
View More
Share Statistics
- Shares Outstanding 41.33 million
- Shares Float 63.85 million
- % Held by Insiders 1024%
- % Held by Institutions 2.73%
- Shares Short 2.17 million
- Shares Short Prior Month 2.21 million
- Short Ratio 4.18
- Short % of Float 3%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta -0.54
- 52 Week High $0.94
- 52 Week Low $0.37
- 50 Day Moving Average 0.73
- 200 Day Moving Average 0.61
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
9 Meters Biopharma, Inc (INNT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
9 Meters Biopharma, Inc (INNT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2019-12-31 | 2020-03-20 | $N/A | -$0.23 | ||
| 2019-09-30 | 2019-11-07 | $N/A | -$0.26 | -$0.14 | -85.71% |
| 2019-06-30 | 2019-08-08 | $N/A | -$0.13 | -$0.13 | 0% |
| 2019-03-31 | 2019-05-10 | $N/A | -$0.16 | -$0.12 | -33.33% |
| 2018-12-31 | 2019-03-18 | $N/A | -$0.12 | -$0.21 | 44.95% |
| 2018-09-30 | 2018-11-13 | $N/A | -$0.03 | -$0.21 | 85.71% |
| 2018-06-30 | 2018-08-14 | $N/A | -$0.16 | -$0.21 | 23.81% |
| 2018-03-31 | 2018-05-15 | $N/A | -$0.76 | ||
| 2017-12-31 | 2018-03-13 | $N/A | -$3.16 | ||
| 2017-09-30 | 2017-09-30 | $N/A | -$1.61 | ||
| 2017-06-30 | 2017-06-30 | $N/A | -$1.94 | ||
| 2017-03-31 | 2017-03-31 | $N/A | -$2.80 | ||
| 2016-12-31 | 2016-12-31 | $N/A | -$1.71 | ||
| 2016-09-30 | 2016-09-30 | $N/A | -$2.65 |
9 Meters Biopharma, Inc (INNT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | 444817 | 2.6 million | 5.5 million | 3.94 million | 3.07 million |
| Income Before Tax | -44.6 million | -3.6 million | -8.9 million | -9.22 million | -4.49 million |
| Selling General Administrative | 5.66 million | 1.67 million | 2.14 million | 2.56 million | 3.05 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | -43.57 million | -3.02 million | -7.64 million | -6.51 million | -6.12 million |
| Operating Income | -6.1 million | -4.27 million | -7.64 million | -6.51 million | -6.12 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | -37.48 million | 1.23 million | -1.27 million | -2.71 million | 1.63 million |
| Net Income From Continuing Operations | -44.6 million | -3.6 million | -8.9 million | -9.22 million | -4.49 million |
| Net Income Applicable to Common Shares | N/A | N/A | -8.9 million | -9.22 million | -4.49 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | -3.19 million | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | 833192 | 350473 | -1.22 million |
| Total Cash Flow from Investing Activities | N/A | N/A | -2459 | N/A | -9475 |
| Net Borrowings | N/A | N/A | -1.04 million | -500000 | N/A |
| Total Cash Flow from Financial Activities | 20.19 million | 707196 | -1.04 million | -485510 | 8.37 million |
| Change to Operating Activities | N/A | N/A | 3.11 million | 1.21 million | -217443 |
| Change in Cash | 10.81 million | -1.93 million | -4.27 million | -4.47 million | 1.84 million |
| Total Cash from Operating Activities | -6.2 million | -2.63 million | -3.22 million | -3.99 million | -6.52 million |
| Depreciation | 4461 | 5284 | 5503 | 5691 | 5274 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | -876786 |
| Change to Net Income | N/A | N/A | 1.38 million | 3.34 million | -1 million |
| Capital Expenditures | N/A | N/A | 2459 | N/A | 9475 |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 11.61 million | 15.84 million | 14.91 million | 13.13 million | 9.63 million |
| Total Stockholder Equity | 3.07 million | -12.55 million | -9.61 million | -3.31 million | 5.01 million |
| Other Current Liabilities | 247000 | 1.5 million | 3.05 million | 3.96 million | 1.66 million |
| Total Assets | 14.68 million | 3.29 million | 5.3 million | 9.81 million | 14.64 million |
| Common Stock | N/A | N/A | 3948 | 3589 | 3589 |
| Other Current Assets | N/A | N/A | 75000 | 75000 | 75000 |
| Retained Earnings | -118.77 million | -74.17 million | -70.56 million | -61.66 million | -52.44 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | 5580 | 5580 | 5580 |
| Cash | 13.47 million | 2.67 million | 4.59 million | 8.86 million | 13.34 million |
| Total Current Liabilities | 11.61 million | 15.84 million | 14.91 million | 13.13 million | 9.62 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | N/A | N/A | 68252 | 84741 | 103482 |
| Total Current Assets | 14.61 million | 3.23 million | 5.22 million | 9.72 million | 14.53 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | N/A | N/A | -9.61 million | -3.31 million | 5.01 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 3.45 million | 5.08 million | 3.89 million | 3.06 million | 2.71 million |
9 Meters Biopharma, Inc (INNT) Chart:
9 Meters Biopharma, Inc (INNT) News:
Below you will find a list of latest news for 9 Meters Biopharma, Inc (INNT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
9 Meters Biopharma, Inc (INNT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
9 Meters Biopharma, Inc (INNT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000208/0001551986-20-000208-index.htm |
| 2019-05-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000019008901/0000000000-19-008901-index.htm |
| 2020-05-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000020004250/0000000000-20-004250-index.htm |
| 2020-06-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000020004955/0000000000-20-004955-index.htm |
| 2020-06-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000020005211/0000000000-20-005211-index.htm |
| 2020-08-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000020007764/0000000000-20-007764-index.htm |
| 2020-09-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1551986/000000000020008329/0000000000-20-008329-index.htm |
| 2020-05-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1551986/000094787120000465/0000947871-20-000465-index.htm |
| 2020-07-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1551986/000094787120000648/0000947871-20-000648-index.htm |
| 2020-09-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1551986/000117891320002553/0001178913-20-002553-index.htm |
| 2018-08-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000012/0001551986-18-000012-index.htm |
| 2018-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000014/0001551986-18-000014-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/0001551986-18-000020-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000021/0001551986-18-000021-index.htm |
| 2018-08-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000025/0001551986-18-000025-index.htm |
| 2018-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000026/0001551986-18-000026-index.htm |
| 2018-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000027/0001551986-18-000027-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000029/0001551986-18-000029-index.htm |
| 2018-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000031/0001551986-18-000031-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000033/0001551986-18-000033-index.htm |
| 2018-10-04 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000036/0001551986-18-000036-index.htm |
| 2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000039/0001551986-18-000039-index.htm |
| 2018-10-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000042/0001551986-18-000042-index.htm |
| 2018-10-18 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000043/0001551986-18-000043-index.htm |
| 2018-10-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000045/0001551986-18-000045-index.htm |
| 2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000047/0001551986-18-000047-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000049/0001551986-18-000049-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000051/0001551986-18-000051-index.htm |
| 2018-11-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000053/0001551986-18-000053-index.htm |
| 2018-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000055/0001551986-18-000055-index.htm |
| 2018-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000057/0001551986-18-000057-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/0001551986-18-000060-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000061/0001551986-18-000061-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000067/0001551986-18-000067-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000068/0001551986-18-000068-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000069/0001551986-18-000069-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000070/0001551986-18-000070-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000072/0001551986-18-000072-index.htm |
| 2018-12-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000075/0001551986-18-000075-index.htm |
| 2018-12-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000076/0001551986-18-000076-index.htm |
| 2018-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000078/0001551986-18-000078-index.htm |
| 2019-01-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000002/0001551986-19-000002-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000005/0001551986-19-000005-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000007/0001551986-19-000007-index.htm |
| 2019-03-15 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000008/0001551986-19-000008-index.htm |
| 2019-03-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000015/0001551986-19-000015-index.htm |
| 2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000019/0001551986-19-000019-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000021/0001551986-19-000021-index.htm |
| 2019-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000023/0001551986-19-000023-index.htm |
| 2019-04-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000024/0001551986-19-000024-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000027/0001551986-19-000027-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000029/0001551986-19-000029-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000030/0001551986-19-000030-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000033/0001551986-19-000033-index.htm |
| 2019-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000038/0001551986-19-000038-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000042/0001551986-19-000042-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000046/0001551986-19-000046-index.htm |
| 2019-05-14 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000047/0001551986-19-000047-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000050/0001551986-19-000050-index.htm |
| 2019-05-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000052/0001551986-19-000052-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000054/0001551986-19-000054-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000056/0001551986-19-000056-index.htm |
| 2019-05-31 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000060/0001551986-19-000060-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000061/0001551986-19-000061-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000062/0001551986-19-000062-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000064/0001551986-19-000064-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000065/0001551986-19-000065-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000070/0001551986-19-000070-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000072/0001551986-19-000072-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000075/0001551986-19-000075-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000077/0001551986-19-000077-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000080/0001551986-19-000080-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000082/0001551986-19-000082-index.htm |
| 2019-07-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000084/0001551986-19-000084-index.htm |
| 2019-07-03 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000089/0001551986-19-000089-index.htm |
| 2019-07-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000090/0001551986-19-000090-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000091/0001551986-19-000091-index.htm |
| 2019-07-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000093/0001551986-19-000093-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000101/0001551986-19-000101-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000102/0001551986-19-000102-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000106/0001551986-19-000106-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000107/0001551986-19-000107-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000109/0001551986-19-000109-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000114/0001551986-19-000114-index.htm |
| 2019-11-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000117/0001551986-19-000117-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000119/0001551986-19-000119-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000121/0001551986-19-000121-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000127/0001551986-19-000127-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000129/0001551986-19-000129-index.htm |
| 2019-12-30 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000131/0001551986-19-000131-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000003/0001551986-20-000003-index.htm |
| 2020-01-17 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000004/0001551986-20-000004-index.htm |
| 2020-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000008/0001551986-20-000008-index.htm |
| 2020-01-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000009/0001551986-20-000009-index.htm |
| 2020-01-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000012/0001551986-20-000012-index.htm |
| 2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000018/0001551986-20-000018-index.htm |
| 2020-02-12 | SC TO-I | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000019/0001551986-20-000019-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000021/0001551986-20-000021-index.htm |
| 2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000023/0001551986-20-000023-index.htm |
| 2020-02-20 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000029/0001551986-20-000029-index.htm |
| 2020-02-28 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000035/0001551986-20-000035-index.htm |
| 2020-03-11 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000041/0001551986-20-000041-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000043/0001551986-20-000043-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000046/0001551986-20-000046-index.htm |
| 2020-03-20 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000049/0001551986-20-000049-index.htm |
| 2020-03-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000050/0001551986-20-000050-index.htm |
| 2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000052/0001551986-20-000052-index.htm |
| 2020-03-30 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000054/0001551986-20-000054-index.htm |
| 2020-04-06 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000057/0001551986-20-000057-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000058/0001551986-20-000058-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000060/0001551986-20-000060-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000062/0001551986-20-000062-index.htm |
| 2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000066/0001551986-20-000066-index.htm |
| 2020-04-22 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000067/0001551986-20-000067-index.htm |
| 2020-05-01 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000072/0001551986-20-000072-index.htm |
| 2020-05-01 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000073/0001551986-20-000073-index.htm |
| 2020-05-01 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000074/0001551986-20-000074-index.htm |
| 2020-05-01 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000077/0001551986-20-000077-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000103/0001551986-20-000103-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000104/0001551986-20-000104-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000105/0001551986-20-000105-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000106/0001551986-20-000106-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000107/0001551986-20-000107-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000108/0001551986-20-000108-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000109/0001551986-20-000109-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000110/0001551986-20-000110-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000113/0001551986-20-000113-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000116/0001551986-20-000116-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000117/0001551986-20-000117-index.htm |
| 2020-05-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000118/0001551986-20-000118-index.htm |
| 2020-05-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000119/0001551986-20-000119-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000120/0001551986-20-000120-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000121/0001551986-20-000121-index.htm |
| 2020-05-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000124/0001551986-20-000124-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000125/0001551986-20-000125-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000126/0001551986-20-000126-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000127/0001551986-20-000127-index.htm |
| 2020-05-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000130/0001551986-20-000130-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000131/0001551986-20-000131-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000136/0001551986-20-000136-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000137/0001551986-20-000137-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000138/0001551986-20-000138-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000142/0001551986-20-000142-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000144/0001551986-20-000144-index.htm |
| 2020-05-15 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000146/0001551986-20-000146-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000153/0001551986-20-000153-index.htm |
| 2020-05-15 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000154/0001551986-20-000154-index.htm |
| 2020-05-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000155/0001551986-20-000155-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000157/0001551986-20-000157-index.htm |
| 2020-06-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000160/0001551986-20-000160-index.htm |
| 2020-06-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000163/0001551986-20-000163-index.htm |
| 2020-06-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000164/0001551986-20-000164-index.htm |
| 2020-06-12 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000169/0001551986-20-000169-index.htm |
| 2020-06-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000170/0001551986-20-000170-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000172/0001551986-20-000172-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000174/0001551986-20-000174-index.htm |
| 2020-06-18 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000177/0001551986-20-000177-index.htm |
| 2020-06-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000178/0001551986-20-000178-index.htm |
| 2020-06-19 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000181/0001551986-20-000181-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000183/0001551986-20-000183-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000185/0001551986-20-000185-index.htm |
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000188/0001551986-20-000188-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000192/0001551986-20-000192-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000194/0001551986-20-000194-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000202/0001551986-20-000202-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000203/0001551986-20-000203-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000204/0001551986-20-000204-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000205/0001551986-20-000205-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000206/0001551986-20-000206-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000207/0001551986-20-000207-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000208/0001551986-20-000208-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000210/0001551986-20-000210-index.htm |
| 2020-07-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000219/0001551986-20-000219-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000220/0001551986-20-000220-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000221/0001551986-20-000221-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000222/0001551986-20-000222-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000223/0001551986-20-000223-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000224/0001551986-20-000224-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000225/0001551986-20-000225-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000226/0001551986-20-000226-index.htm |
| 2020-07-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000228/0001551986-20-000228-index.htm |
| 2020-07-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000233/0001551986-20-000233-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000234/0001551986-20-000234-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000236/0001551986-20-000236-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000238/0001551986-20-000238-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000241/0001551986-20-000241-index.htm |
| 2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000244/0001551986-20-000244-index.htm |
| 2020-08-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000246/0001551986-20-000246-index.htm |
| 2020-08-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000248/0001551986-20-000248-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000249/0001551986-20-000249-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000251/0001551986-20-000251-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000253/0001551986-20-000253-index.htm |
| 2020-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000257/0001551986-20-000257-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000258/0001551986-20-000258-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000259/0001551986-20-000259-index.htm |
| 2020-08-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000261/0001551986-20-000261-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000263/0001551986-20-000263-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000265/0001551986-20-000265-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000267/0001551986-20-000267-index.htm |
| 2020-10-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000270/0001551986-20-000270-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000272/0001551986-20-000272-index.htm |
| 2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000274/0001551986-20-000274-index.htm |
| 2020-10-08 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000278/0001551986-20-000278-index.htm |
| 2020-10-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000282/0001551986-20-000282-index.htm |
| 2020-10-09 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000283/0001551986-20-000283-index.htm |
| 2019-07-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1551986/999999999519001581/9999999995-19-001581-index.htm |
| 2020-06-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1551986/999999999520001489/9999999995-20-001489-index.htm |
| 2020-10-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1551986/999999999520002814/9999999995-20-002814-index.htm |
| 2020-10-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1551986/999999999520002875/9999999995-20-002875-index.htm |
| 2018-11-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1551986/999999999718009232/9999999997-18-009232-index.htm |
| 2019-01-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1551986/999999999719000073/9999999997-19-000073-index.htm |
9 Meters Biopharma, Inc (INNT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of 9 Meters Biopharma, Inc (INNT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1024%Institutional Ownership: 273%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-08-24 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 100.00 | 4.85 | 485.00 | 100.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2018-08-28 | Christopher P. Prior | Chief Executive Officer | Buy | 1,000.00 | 4.93 | 4,930.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000021/0001551986-18-000021-index.htm |
| 2018-08-28 | Sandeep Laumas | Executive Chairman | Buy | 405.00 | 5.08 | 2,057.40 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/0001551986-18-000020-index.htm |
| 2019-05-22 | Sandeep Laumas | CEO, Executive Chairman | Buy | 5,000.00 | 1.38 | 6,900.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000054/0001551986-19-000054-index.htm |
| 2018-08-30 | Christopher P. Prior | Chief Executive Officer | Buy | 309.00 | 5.20 | 1,606.80 | 1,309.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000026/0001551986-18-000026-index.htm |
| 2019-06-13 | Sandeep Laumas | CEO, Executive Chairman | Buy | 409.00 | 1.21 | 494.89 | 13,409.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000077/0001551986-19-000077-index.htm |
| 2018-08-24 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 500.00 | 4.85 | 2,425.00 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2018-11-30 | Roy Proujansky | Director | Buy | 1,400.00 | 2.63 | 3,682.00 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000061/0001551986-18-000061-index.htm |
| 2019-06-13 | Sandeep Laumas | CEO, Executive Chairman | Buy | 591.00 | 1.22 | 721.02 | 14,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000077/0001551986-19-000077-index.htm |
| 2019-06-28 | Sandeep Laumas | CEO, Executive Chairman | Buy | 4,000.00 | 1.15 | 4,600.00 | 18,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000082/0001551986-19-000082-index.htm |
| 2018-09-12 | Christopher P. Prior | Chief Executive Officer | Buy | 500.00 | 6.13 | 3,065.00 | 1,809.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000031/0001551986-18-000031-index.htm |
| 2018-09-07 | Sandeep Laumas | Executive Chairman | Buy | 500.00 | 6.10 | 3,050.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000029/0001551986-18-000029-index.htm |
| 2018-09-14 | Christopher P. Prior | Chief Executive Officer | Buy | 200.00 | 5.82 | 1,164.00 | 2,009.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000033/0001551986-18-000033-index.htm |
| 2020-09-11 | Mark A Sirgo | Director | Buy | 21,485.00 | 0.65 | 14,003.92 | 21,485.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000267/0001551986-20-000267-index.htm |
| 2020-06-30 | John Temperato | Chief Executive Officer | Buy | 189,655.00 | 239,096.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000192/0001551986-20-000192-index.htm | ||
| 2019-05-24 | Roy Proujansky | Director | Buy | 1,000.00 | 1.28 | 1,280.00 | 2,400.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000056/0001551986-19-000056-index.htm |
| 2018-08-28 | Sandeep Laumas | Executive Chairman | Buy | 0.00 | 4.90 | 250.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/0001551986-18-000020-index.htm | |
| 2018-11-29 | Sandeep Laumas | Executive Chairman | Buy | 1,000.00 | 2.55 | 2,550.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000055/0001551986-18-000055-index.htm |
| 2020-08-20 | Michael T. Constantino | Director | Buy | 34,108.00 | 0.75 | 25,581.00 | 34,108.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000258/0001551986-20-000258-index.htm |
| 2020-08-17 | Mark A Sirgo | Director | Buy | 100,000.00 | 0.56 | 56,000.00 | 411,784.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000253/0001551986-20-000253-index.htm |
| 2020-09-10 | Mark A Sirgo | Director | Buy | 50,000.00 | 0.60 | 30,000.00 | 461,784.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000267/0001551986-20-000267-index.htm |
| 2020-06-15 | John Temperato | Chief Executive Officer | Buy | 10,000.00 | 0.60 | 5,971.00 | 49,441.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000172/0001551986-20-000172-index.htm |
| 2018-08-24 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 400.00 | 4.99 | 1,996.00 | 500.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2018-08-28 | Sandeep Laumas | Executive Chairman | Buy | 250.00 | 4.88 | 1,220.00 | 500.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/0001551986-18-000020-index.htm |
| 2018-11-29 | Sandeep Laumas | Executive Chairman | Buy | 2,000.00 | 2.56 | 5,120.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000055/0001551986-18-000055-index.htm |
| 2020-09-11 | Mark A Sirgo | Director | Buy | 77,000.00 | 0.68 | 52,360.00 | 538,784.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000267/0001551986-20-000267-index.htm |
| 2020-08-17 | John Temperato | Chief Executive Officer | Buy | 35,000.00 | 0.57 | 19,831.00 | 545,496.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000251/0001551986-20-000251-index.htm |
| 2018-08-27 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 47.00 | 4.90 | 230.30 | 547.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2020-06-15 | Mark A Sirgo | Director | Buy | 17,943.00 | 0.60 | 10,720.94 | 57,384.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000174/0001551986-20-000174-index.htm |
| 2018-08-28 | Sandeep Laumas | Executive Chairman | Buy | 95.00 | 5.07 | 481.65 | 595.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/0001551986-18-000020-index.htm |
| 2018-11-30 | Sandeep Laumas | Executive Chairman | Buy | 1,000.00 | 2.64 | 2,640.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/0001551986-18-000060-index.htm |
| 2020-08-21 | John Temperato | Chief Executive Officer | Buy | 70,000.00 | 0.69 | 48,300.00 | 615,496.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198620000259/0001551986-20-000259-index.htm |
| 2018-11-30 | Sandeep Laumas | Executive Chairman | Buy | 1,000.00 | 2.62 | 2,620.00 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/0001551986-18-000060-index.htm |
| 2018-11-29 | Christopher P. Prior | Chief Executive Officer | Buy | 5,000.00 | 2.75 | 13,750.00 | 7,009.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000057/0001551986-18-000057-index.htm |
| 2018-08-30 | Sandeep Laumas | Executive Chairman | Buy | 500.00 | 5.24 | 2,620.00 | 750.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000027/0001551986-18-000027-index.htm |
| 2018-08-27 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 253.00 | 4.96 | 1,254.88 | 800.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |
| 2018-11-30 | Sandeep Laumas | Executive Chairman | Buy | 1,000.00 | 2.63 | 2,630.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/0001551986-18-000060-index.htm |
| 2019-05-30 | Jay P. Madan | President | Buy | 5,000.00 | 1.32 | 6,600.00 | 84,131.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198619000062/0001551986-19-000062-index.htm |
| 2018-08-27 | June Sherie Almenoff | COO and Chief Medical Officer | Buy | 100.00 | 4.94 | 494.00 | 900.00 | https://www.sec.gov/Archives/edgar/data/1551986/000155198618000017/0001551986-18-000017-index.htm |